{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:31:19Z","timestamp":1684564279011},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00467-010-1611-1","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T04:02:39Z","timestamp":1280376159000},"page":"2311-2319","source":"Crossref","is-referenced-by-count":2,"title":["Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium"],"prefix":"10.1007","volume":"25","author":[{"given":"Pornpimol","family":"Rianthavorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Ettenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz D.","family":"Kuizon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,30]]},"reference":[{"key":"1611_CR1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","volume":"33","author":"IB Salusky","year":"1988","unstructured":"Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975\u2013982","journal-title":"Kidney Int"},{"key":"1611_CR2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","volume":"54","author":"IB Salusky","year":"1998","unstructured":"Salusky IB, Kuizon BD, Belin TR, Ramirez JA, Gales B, Segre GV, Goodman WG (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54:907\u2013914","journal-title":"Kidney Int"},{"key":"1611_CR3","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1210\/endo.141.4.7436","volume":"141","author":"CP Sanchez","year":"2000","unstructured":"Sanchez CP, Kuizon BD, Abdella PA, Juppner H, Salusky IB, Goodman WG (2000) Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure. Endocrinology 141:1536\u20131544","journal-title":"Endocrinology"},{"key":"1611_CR4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12178-009-9046-7","volume":"2","author":"HL Wright","year":"2009","unstructured":"Wright HL, McCarthy HS, Middleton J, Marshall MJ (2009) RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med 2:56\u201364","journal-title":"Curr Rev Musculoskelet Med"},{"key":"1611_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"1611_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jmicro\/51.5.315","volume":"51","author":"M Shimizu-Ishiura","year":"2002","unstructured":"Shimizu-Ishiura M, Kawana F, Sasaki T (2002) Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function. J Electron Microsc (Tokyo) 51:315\u2013325","journal-title":"J Electron Microsc (Tokyo)"},{"key":"1611_CR7","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1046\/j.1523-1755.1998.00199.x","volume":"54","author":"CP Sanchez","year":"1998","unstructured":"Sanchez CP, Salusky IB, Kuizon BD, Abdella P, Juppner H, Goodman WG (1998) Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879\u20131887","journal-title":"Kidney Int"},{"key":"1611_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000143476","volume":"76","author":"WA Merz","year":"1970","unstructured":"Merz WA, Schenk RK (1970) A quantitative histological study on bone formation in human cancellous bone. Acta Anat (Basel) 76:1\u201315","journal-title":"Acta Anat (Basel)"},{"key":"1611_CR9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"1611_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.ASN.0000039565.56011.BE","volume":"14","author":"CP Sanchez","year":"2003","unstructured":"Sanchez CP, He YZ (2003) Effects of thyroparathyroidectomy, exogenous calcium, and short-term calcitriol therapy on the growth plate in renal failure. J Am Soc Nephrol 14:148\u2013158","journal-title":"J Am Soc Nephrol"},{"key":"1611_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","volume":"15","author":"S Theoleyre","year":"2004","unstructured":"Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D (2004) The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15:457\u2013475","journal-title":"Cytokine Growth Factor Rev"},{"key":"1611_CR12","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","volume":"140","author":"SK Lee","year":"1999","unstructured":"Lee SK, Lorenzo JA (1999) Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140:3552\u20133561","journal-title":"Endocrinology"},{"key":"1611_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcb.10490","volume":"89","author":"RM Locklin","year":"2003","unstructured":"Locklin RM, Khosla S, Turner RT, Riggs BL (2003) Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89:180\u2013190","journal-title":"J Cell Biochem"},{"key":"1611_CR14","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2003-032066","volume":"89","author":"EC Buxton","year":"2004","unstructured":"Buxton EC, Yao W, Lane NE (2004) Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1\u201334). J Clin Endocrinol Metab 89:3332\u20133336","journal-title":"J Clin Endocrinol Metab"},{"key":"1611_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","volume":"15","author":"RJ Lund","year":"2004","unstructured":"Lund RJ, Davies MR, Brown AJ, Hruska KA (2004) Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol 15:359\u2013369","journal-title":"J Am Soc Nephrol"},{"key":"1611_CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","volume":"29","author":"AE Kearns","year":"2008","unstructured":"Kearns AE, Khosla S, Kostenuik PJ (2008) Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155\u2013192","journal-title":"Endocr Rev"},{"key":"1611_CR17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","volume":"93","author":"TH Vu","year":"1998","unstructured":"Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z (1998) MMP-9\/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411\u2013422","journal-title":"Cell"},{"key":"1611_CR18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1439-0264.2008.00920.x","volume":"38","author":"MS Kim","year":"2009","unstructured":"Kim MS, Kim JH, Lee MR, Kang JH, Kim HJ, Ko HM, Choi CH, Jung JY, Koh JT, Kim BK, Oh HK, Kim WJ, Lee EJ, Kim SH (2009) Effects of alendronate on a disintegrin and metalloproteinase with thrombospondin motifs expression in the developing epiphyseal cartilage in rats. Anat Histol Embryol 38:154\u2013160","journal-title":"Anat Histol Embryol"},{"key":"1611_CR19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.bone.2008.01.010","volume":"42","author":"J Liu","year":"2008","unstructured":"Liu J, Xu K, Wen G, Guo H, Li S, Wu X, Dai R, Sheng Z, Liao E (2008) Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice. Bone 42:950\u2013959","journal-title":"Bone"},{"key":"1611_CR20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2009.06.011","volume":"45","author":"X Li","year":"2009","unstructured":"Li X, Ominsky MS, Stolina M, Warmington KS, Geng Z, Niu QT, Asuncion FJ, Tan HL, Grisanti M, Dwyer D, Adamu S, Ke HZ, Simonet WS, Kostenuik PJ (2009) Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin. Bone 45:669\u2013676","journal-title":"Bone"},{"key":"1611_CR21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00774-007-0785-5","volume":"26","author":"KK Doumouchtsis","year":"2008","unstructured":"Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Tziamalis MP, Stathakis CP, Diamanti-Kandarakis E, Dimitroulis D, Perrea DN (2008) Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J Bone Miner Metab 26:66\u201372","journal-title":"J Bone Miner Metab"},{"key":"1611_CR22","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","volume":"95","author":"P Collin-Osdoby","year":"2004","unstructured":"Collin-Osdoby P (2004) Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 95:1046\u20131057","journal-title":"Circ Res"},{"issue":"Suppl 10","key":"1611_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/17.suppl_10.2","volume":"17","author":"M Fukagawa","year":"2002","unstructured":"Fukagawa M, Kazama JJ, Kurokawa K (2002) Renal osteodystrophy and secondary hyperparathyroidism. Nephrol Dial Transplant 17[Suppl 10]:2\u20135","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"1611_CR24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","volume":"9","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9[Suppl 1]:S1","journal-title":"Arthritis Res Ther"},{"key":"1611_CR25","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI116872","volume":"92","author":"R Balena","year":"1993","unstructured":"Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D (1993) The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577\u20132586","journal-title":"J Clin Invest"},{"key":"1611_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2005.04.041","volume":"37","author":"LC Yang","year":"2005","unstructured":"Yang LC, Majeska RJ, Laudier DM, Mann R, Schaffler MB (2005) High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse. Bone 37:287\u2013295","journal-title":"Bone"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00467-010-1611-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T16:45:35Z","timestamp":1551545135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-010-1611-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,30]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1611"],"URL":"https:\/\/doi.org\/10.1007\/s00467-010-1611-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,30]]}}}